Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) (ABX067)
This study has been completed.
Sponsor:
Mt. Sinai Medical Center, Miami
Collaborator:
Celgene Corporation
Information provided by:
Mt. Sinai Medical Center, Miami
ClinicalTrials.gov Identifier:
NCT00625573
First received: February 19, 2008
Last updated: September 17, 2009
Last verified: September 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |